日本ケミファの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/06/07 | 2,340 | 2,340 | 2,260 | 2,260 | -67 | -2.9% | 3,400 |
2021/06/04 | 2,326 | 2,349 | 2,326 | 2,327 | -16 | -0.7% | 500 |
2021/06/03 | 2,331 | 2,343 | 2,331 | 2,343 | +8 | +0.3% | 500 |
2021/06/02 | 2,297 | 2,335 | 2,297 | 2,335 | +13 | +0.6% | 2,000 |
2021/06/01 | 2,349 | 2,350 | 2,319 | 2,322 | -5 | -0.2% | 1,800 |
2021/05/31 | 2,350 | 2,350 | 2,304 | 2,327 | +27 | +1.2% | 800 |
2021/05/28 | 2,297 | 2,306 | 2,297 | 2,300 | -3 | -0.1% | 2,000 |
2021/05/27 | 2,303 | 2,303 | 2,303 | 2,303 | ±0 | ±0% | 300 |
2021/05/26 | 2,300 | 2,312 | 2,297 | 2,303 | -8 | -0.3% | 2,400 |
2021/05/25 | 2,287 | 2,343 | 2,276 | 2,311 | -26 | -1.1% | 2,600 |
2021/05/24 | 2,301 | 2,351 | 2,301 | 2,337 | +24 | +1% | 700 |
2021/05/21 | 2,345 | 2,345 | 2,313 | 2,313 | -22 | -0.9% | 500 |
2021/05/20 | 2,368 | 2,368 | 2,318 | 2,335 | +10 | +0.4% | 2,100 |
2021/05/19 | 2,368 | 2,368 | 2,313 | 2,325 | -43 | -1.8% | 1,500 |
2021/05/18 | 2,304 | 2,368 | 2,304 | 2,368 | +67 | +2.9% | 600 |
2021/05/17 | 2,328 | 2,349 | 2,293 | 2,301 | -27 | -1.2% | 2,000 |
2021/05/14 | 2,352 | 2,363 | 2,320 | 2,328 | +26 | +1.1% | 1,100 |
2021/05/13 | 2,374 | 2,374 | 2,290 | 2,302 | +11 | +0.5% | 2,700 |
2021/05/12 | 2,299 | 2,372 | 2,290 | 2,291 | -8 | -0.3% | 1,600 |
2021/05/11 | 2,345 | 2,345 | 2,294 | 2,299 | -46 | -2% | 1,900 |
2021/05/10 | 2,371 | 2,381 | 2,340 | 2,345 | -25 | -1.1% | 2,200 |
2021/05/07 | 2,410 | 2,443 | 2,319 | 2,370 | +60 | +2.6% | 5,600 |
2021/05/06 | 2,314 | 2,337 | 2,310 | 2,310 | +46 | +2% | 1,300 |
2021/04/30 | 2,372 | 2,384 | 2,256 | 2,264 | -127 | -5.3% | 2,200 |
2021/04/28 | 2,400 | 2,400 | 2,391 | 2,391 | -9 | -0.4% | 1,400 |
2021/04/27 | 2,420 | 2,429 | 2,400 | 2,400 | -39 | -1.6% | 1,700 |
2021/04/26 | 2,488 | 2,488 | 2,430 | 2,439 | +1 | ±0% | 1,900 |
2021/04/23 | 2,436 | 2,444 | 2,436 | 2,438 | +2 | +0.1% | 600 |
2021/04/22 | 2,485 | 2,485 | 2,436 | 2,436 | +1 | ±0% | 600 |
2021/04/21 | 2,467 | 2,467 | 2,435 | 2,435 | -32 | -1.3% | 4,000 |
2021/04/20 | 2,470 | 2,484 | 2,467 | 2,467 | -18 | -0.7% | 1,700 |
2021/04/19 | 2,461 | 2,486 | 2,461 | 2,485 | -3 | -0.1% | 1,300 |
2021/04/16 | 2,483 | 2,494 | 2,468 | 2,488 | +55 | +2.3% | 1,500 |
2021/04/15 | 2,447 | 2,447 | 2,427 | 2,433 | -14 | -0.6% | 700 |
2021/04/14 | 2,525 | 2,525 | 2,428 | 2,447 | -1 | ±0% | 2,500 |
2021/04/13 | 2,456 | 2,464 | 2,448 | 2,448 | -8 | -0.3% | 1,500 |
2021/04/12 | 2,427 | 2,490 | 2,427 | 2,456 | ±0 | ±0% | 3,700 |
2021/04/09 | 2,455 | 2,456 | 2,438 | 2,456 | +1 | ±0% | 1,100 |
2021/04/08 | 2,439 | 2,470 | 2,439 | 2,455 | +26 | +1.1% | 2,500 |
2021/04/07 | 2,411 | 2,431 | 2,411 | 2,429 | -9 | -0.4% | 1,500 |
2021/04/06 | 2,450 | 2,451 | 2,414 | 2,438 | -12 | -0.5% | 3,900 |
2021/04/05 | 2,483 | 2,483 | 2,405 | 2,450 | -53 | -2.1% | 8,100 |
2021/04/02 | 2,558 | 2,558 | 2,503 | 2,503 | -68 | -2.6% | 3,200 |
2021/04/01 | 2,628 | 2,628 | 2,562 | 2,571 | -59 | -2.2% | 4,600 |
2021/03/31 | 2,632 | 2,639 | 2,600 | 2,630 | -1 | ±0% | 2,500 |
2021/03/30 | 2,549 | 2,631 | 2,471 | 2,631 | +43 | +1.7% | 6,000 |
2021/03/29 | 2,558 | 2,592 | 2,514 | 2,588 | +29 | +1.1% | 8,300 |
2021/03/26 | 2,535 | 2,568 | 2,480 | 2,559 | +24 | +0.9% | 6,800 |
2021/03/25 | 2,520 | 2,570 | 2,502 | 2,535 | +65 | +2.6% | 5,000 |
2021/03/24 | 2,435 | 2,519 | 2,420 | 2,470 | +31 | +1.3% | 13,100 |
851~
900
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
日ケミファ | 151,100円 | +2.5% | - | 3.31% | 90.86倍 | 0.29倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
ティムス | 20,500円 | - | - | 0.00% | - | 2.78倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補品を香港拠点ジーシンに導出 |
ノイルイミューン | 17,300円 | -97.8% | - | 0.00% | - | 1.50倍 |
|
独自技術用いたCAR-T細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
カルナバイオ | 31,000円 | -43.1% | - | 0.00% | - | 1.84倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
VIS | 89,000円 | +87.8% | +265.7% | 0.00% | 53.45倍 | 2.45倍 |
|
mRNA標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
市場注目の銘柄
チャート関連のコラム